- TG Therapeutics (NASDAQ:TGTX): Q2 EPS of -$0.29 misses by $0.13.
- License revenue of $38,095 beats by $8K. (PR)
TG Therapeutics posts Q2 results
Recommended For You
More Trending News
About TGTX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TGTX | - | - |
| TG Therapeutics, Inc. | ||